> COR – Anyone know what is driving this higher today? Was something said at the Roth Conference?<
Dr. Stoll, who normally has a droll speaking style, was unusually animated. (I thought he was on amphetamines, or perhaps CX-717.)
More important, Stoll expressed confidence that COR will be able to get the FDA hold on CX-717 lifted based on the argument that the observed histopathology in animals is an artifact. He cited a “clean” electron-microscope analysis as the basis for the newfound confidence.
Market Data 
Markets 
AI
